Webinar Overview
Early and rapid detection of viral respiratory pathogens is vital in the fight against them, and genomic surveillance an essential tool.
In this webinar, we will hear from Dr. Daniel Maloney on whole genome amplification of, and characterisation of Respiratory Syncytial Virus (RSV) A and B. He will discuss the group’s results from eight laboratories in five countries, providing insight into the circulating diversity of RSV. By contrast, Dr. Nick Gauthier will describe an end-to-end, metagenomic next-generation sequencing (mNGS) assay for the pathogen-agnostic detection of respiratory viruses.
In this webinar, viewers will learn:
How you can use nanopore technology for viral respiratory pathogen surveillance.
How to perform targeted viral sequencing of Respiratory Syncytial Virus for the purposes of genomic surveillance.
About the potential utility of metagenomic nanopore sequencing for infection control and public health surveillance.
Meet the speakers
)
Dr. Daniel Maloney, Postdoctoral researcher, NHS Lothian
Daniel works in the University of Edinburgh as a postdoctoral researcher, where his work centres on ...
)
Translating metagenomics from research to clinic
Dr. Nick Gauthier, Research Program Manager & Senior Scientist, Bugseq
Dr. Gauthier has a background in NGS-assay development using the nanopore sequencing platform. Throu...
)
Anna Maria Niewiadomska, Segment market manger – public health, Oxford Nanopore Technologies
In her role as segment market manager, Anna drives the development of new markets in the infectious ...
